Joseph S. Zakrzewski - Apr 10, 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
Stock symbol
ANTX
Transactions as of
Apr 10, 2025
Transactions value $
$0
Form type
4
Date filed
4/11/2025, 05:08 PM
Previous filing
Dec 23, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +10.5K +7.79% $0.00 146K Apr 10, 2025 Direct F1
holding ANTX Common Stock 406K Apr 10, 2025 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
F2 These shares are held by Z3 Trust, for which the Reporting Person is a trustee.